BioTech Scout

Discover the most promising early-stage companies in life sciences, scouted by BioPharmaTrend. Follow company news and important business events.

back to Directory

Valence Discovery (acquired by Recursion Pharmaceuticals)

Valence Discovery logo


Valence is building the world's most powerful chemistry engine, unlocking new therapeutic options for patients with previously intractable diseases. Valence is proudly headquartered at Mila, the world’s largest deep learning research institute.

Posts Mentioning This Company

Tech-First Companies Take the Lead in AI Drug Discovery

In recent news, Recursion (NASDAQ: RXRX), a prominent clinical stage TechBio firm, has announced the signing of agreements to acquire Cyclica and Valence, two companies with expertise in AI-enabled drug discovery. These acquisitions strengthen Recursion's position in computational chemistry, machine learning, and artificial intelligence, enhancing its technology-enabled drug discovery capabilities …